ES8301210A1 - Un procedimiento para la preparacion de un derivado del indol. - Google Patents

Un procedimiento para la preparacion de un derivado del indol.

Info

Publication number
ES8301210A1
ES8301210A1 ES504693A ES504693A ES8301210A1 ES 8301210 A1 ES8301210 A1 ES 8301210A1 ES 504693 A ES504693 A ES 504693A ES 504693 A ES504693 A ES 504693A ES 8301210 A1 ES8301210 A1 ES 8301210A1
Authority
ES
Spain
Prior art keywords
formula
migraine
treatment
alkyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES504693A
Other languages
English (en)
Spanish (es)
Other versions
ES504693A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES504693A0 publication Critical patent/ES504693A0/es
Publication of ES8301210A1 publication Critical patent/ES8301210A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
ES504693A 1980-08-12 1981-08-11 Un procedimiento para la preparacion de un derivado del indol. Expired ES8301210A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8026286 1980-08-12

Publications (2)

Publication Number Publication Date
ES504693A0 ES504693A0 (es) 1982-12-01
ES8301210A1 true ES8301210A1 (es) 1982-12-01

Family

ID=10515410

Family Applications (5)

Application Number Title Priority Date Filing Date
ES504693A Expired ES8301210A1 (es) 1980-08-12 1981-08-11 Un procedimiento para la preparacion de un derivado del indol.
ES513933A Expired ES8402268A1 (es) 1980-08-12 1982-07-13 Un procedimiento para la preparacion de un derivado del indol.
ES520783A Expired ES8504706A1 (es) 1980-08-12 1983-03-18 Un procedimiento para la preparacion de un derivado del indol.
ES520784A Granted ES520784A0 (es) 1980-08-12 1983-03-18 Un procedimiento para la preparacion de un derivado del indol.
ES520785A Granted ES520785A0 (es) 1980-08-12 1983-03-18 Un procedimiento para la preparacion de un derivado del indol.

Family Applications After (4)

Application Number Title Priority Date Filing Date
ES513933A Expired ES8402268A1 (es) 1980-08-12 1982-07-13 Un procedimiento para la preparacion de un derivado del indol.
ES520783A Expired ES8504706A1 (es) 1980-08-12 1983-03-18 Un procedimiento para la preparacion de un derivado del indol.
ES520784A Granted ES520784A0 (es) 1980-08-12 1983-03-18 Un procedimiento para la preparacion de un derivado del indol.
ES520785A Granted ES520785A0 (es) 1980-08-12 1983-03-18 Un procedimiento para la preparacion de un derivado del indol.

Country Status (16)

Country Link
US (1) US4650810A (cg-RX-API-DMAC7.html)
JP (1) JPS5764669A (cg-RX-API-DMAC7.html)
AU (1) AU548467B2 (cg-RX-API-DMAC7.html)
BE (1) BE889929A (cg-RX-API-DMAC7.html)
CA (1) CA1169428A (cg-RX-API-DMAC7.html)
CH (1) CH651551A5 (cg-RX-API-DMAC7.html)
DE (1) DE3131728A1 (cg-RX-API-DMAC7.html)
DK (1) DK157920C (cg-RX-API-DMAC7.html)
ES (5) ES8301210A1 (cg-RX-API-DMAC7.html)
FR (1) FR2488607A1 (cg-RX-API-DMAC7.html)
IE (1) IE51491B1 (cg-RX-API-DMAC7.html)
IT (1) IT1171449B (cg-RX-API-DMAC7.html)
NL (1) NL8103769A (cg-RX-API-DMAC7.html)
NZ (1) NZ197996A (cg-RX-API-DMAC7.html)
SE (1) SE454880B (cg-RX-API-DMAC7.html)
ZA (1) ZA815540B (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79215B (cg-RX-API-DMAC7.html) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
EP0225726B1 (en) * 1985-11-08 1991-04-17 Glaxo Group Limited Indole derivatives
GB8530507D0 (en) * 1985-12-11 1986-01-22 Glaxo Group Plc Chemical compounds
US5270333A (en) * 1986-01-28 1993-12-14 Glaxo Group Limited Indole derivatives
GB8607824D0 (en) * 1986-03-27 1986-04-30 Glaxo Group Ltd Chemical compounds
US5399574A (en) * 1990-06-07 1995-03-21 Burroughs Wellcome Co. Indolyl tetrahydropyridines for treating migraine
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
US5254383A (en) * 1992-09-14 1993-10-19 Allied-Signal Inc. Composites having improved penetration resistance and articles fabricated from same
FR2701026B1 (fr) * 1993-02-02 1995-03-31 Adir Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
ES2084560B1 (es) * 1994-03-09 1997-01-16 Almirall Lab Procedimiento de preparacion de derivados el indol.
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US20030096379A1 (en) * 2001-03-28 2003-05-22 Kilgore James L. Method for producing tryptamine derivatives
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
WO2004056769A2 (en) * 2002-12-20 2004-07-08 Ciba Specialty Chemicals Holding Inc. Synthesis of amines and intermediates for the synthesis thereof
ES2538082T3 (es) 2007-02-11 2015-06-17 Map Pharmaceuticals Inc Método de administración terapéutica de DHE para permitir el rápido alivio de migraña mientras que se minimiza el perfil de efectos secundarios
US8173813B2 (en) * 2007-03-23 2012-05-08 Neuraxon, Inc. Quinolone and tetrahydroquinolone and related compounds having NOS inhibitory activity
EP2141148B1 (en) 2007-03-29 2013-07-03 Daiichi Sankyo Company, Limited Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same
US20110171141A1 (en) * 2009-06-26 2011-07-14 Kellerman Donald J Administration of dihydroergotamine mesylate particles using a metered dose inhaler
ES2751388T3 (es) 2011-07-22 2020-03-31 Univ Chicago IGF-1 para su uso en el tratamiento de la jaqueca
AU2013361337A1 (en) 2012-12-21 2015-07-09 Map Pharmaceuticals, Inc. 8'-Hydroxy-Dihydroergotamine compounds and compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3182071A (en) * 1961-06-27 1965-05-04 Warner Lambert Pharmaceutical Acylated indole derivatives
US3472870A (en) * 1966-08-29 1969-10-14 Mead Johnson & Co Sulfonamidotryptamines
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
JPS5764669A (en) 1982-04-19
ZA815540B (en) 1983-03-30
NZ197996A (en) 1985-08-16
IE51491B1 (en) 1987-01-07
BE889929A (fr) 1982-02-11
ES504693A0 (es) 1982-12-01
ES513933A0 (es) 1984-01-16
IE811830L (en) 1982-02-12
NL8103769A (nl) 1982-03-01
ES8402268A1 (es) 1984-01-16
DK357081A (da) 1982-02-13
IT8149084A0 (it) 1981-08-11
CA1169428A (en) 1984-06-19
IT1171449B (it) 1987-06-10
ES8500902A1 (es) 1984-11-01
ES520783A0 (es) 1985-05-01
IT8149084A1 (it) 1983-02-11
US4650810A (en) 1987-03-17
ES520784A0 (es) 1984-11-01
ES8504706A1 (es) 1985-05-01
CH651551A5 (fr) 1985-09-30
SE8104781L (sv) 1982-02-13
DK157920C (da) 1990-08-06
DK157920B (da) 1990-03-05
JPH0247462B2 (cg-RX-API-DMAC7.html) 1990-10-19
AU548467B2 (en) 1985-12-12
DE3131728A1 (de) 1982-03-11
FR2488607A1 (fr) 1982-02-19
ES8500903A1 (es) 1984-11-01
AU7399481A (en) 1982-02-18
SE454880B (sv) 1988-06-06
FR2488607B1 (cg-RX-API-DMAC7.html) 1984-11-16
DE3131728C2 (cg-RX-API-DMAC7.html) 1992-04-30
ES520785A0 (es) 1984-11-01

Similar Documents

Publication Publication Date Title
ES8301210A1 (es) Un procedimiento para la preparacion de un derivado del indol.
ES8205789A1 (es) Un procedimiento para la preparacion de derivados del indol
ES8400415A1 (es) "un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina".
ES8404327A1 (es) Un procedimiento para la preparacion de un derivado del indol.
ES8507479A1 (es) Un metodo para producir un derivado de amina
ES8404346A1 (es) Un procedimiento para la preparacion de diarilpirazinas o triazinas.
ES8300758A1 (es) Un procedimiento para la preparacion de nuevos pirazimil-1,2,4 oxadiazol-5-onas.
ES8603497A1 (es) Procedimiento para preparar derivados de cefalosporina
ES8301966A1 (es) Procedimiento para preparar derivados de pirimidona
ES8303426A1 (es) Un procedimiento para la preparacion de un compuesto de cefalosporina.
ES8301980A1 (es) Procedimiento para la preparacion de 8-arilalcohil-3-fenil-3-nortropanoles .
ES8306750A1 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
ES8305681A1 (es) Procedimiento para la obtencion de fenileteres sustituidos.
ES8307824A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES8403453A1 (es) Un procedimiento para preparar amidas del acido 1-metil-5-p-toluoilpirrol-2-acetico.
ES8305355A1 (es) Un procedimiento para la preparacion de derivados del indol.
ES8305755A1 (es) Procedimiento para preparar derivados de pirimidona.
ES8401034A1 (es) Derivados de quinolina.
ES8300711A1 (es) Un procedimiento para la preparacion de un derivado cis-4,5-disustituidos de imidazolidin-2-ona opticamente activo.
ES8302700A1 (es) "procedimiento para la preparacion de nuevos benzoxazoles y benzotiazoles".
ES8301883A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
ES8301216A1 (es) Un procedimiento para la preparacion de derivados de enantolactama.
ES8606381A1 (es) Un procedimiento para preparar un derivado de uridina.
ES8402557A1 (es) Esteres fenolicos.
ES8303398A1 (es) Un procedimiento para la preparacion de un derivado de 2-piridincarboxamida.